EUVIMEDEUVIMED entdecken
Crossref

A Fully Integrated ICP‐Enriched and Nanozyme‐Catalyzed Lateral Flow Assay for cfDNA Detection in Whole Blood

Fei Cun, Hanxue Li, Haonan Wang, Bin Yang, Jilie Kong, Hui Chen iD

Small · 2025-02 · 21 (8)

DOI: 10.1002/smll.202408101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 23.01.2025. Verfasst von Fei Cun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Fudan University, Shanghai, 200438, China. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, DNA, Viral. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid and sensitive detection of Epstein−Barr virus cell‐free DNA (EBV cfDNA) is crucial for early diagnosis and monitoring of nasopharyngeal carcinoma (NPC), but accessibility to screening is limited by complicated and costly conventional DNA isolation and purification approaches. Here, a fully integrated ion concentration polarization (ICP)‐enriched and nanozyme‐catalyzed lateral flow assay (ICP‐cLFA) is developed, enabling total analysis of EBV cfDNA in whole blood samples, with DNA isolation, pre‐concentration, and amplification performed on a microfluidic chip, consequently providing the signal readout within 75 min. Specifically, ICP preconcentration and amplification steps, together with target recognition catalyzed by a platinum‐decorated mesoporous gold nanosphere (MGNS@Pt) nanozyme, result in an ultralow detection limit of 4 aM in standard cfDNA samples and 100 aM in whole blood from NPC‐bearing rats. The high sensitivity and specificity of the ICP‐cLFA suggest strong potential for cfDNA screening in resource‐limited clinical and field applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsDNA, ViralAnimalsCatalysisHumansGoldHerpesvirus 4, HumanRatsMetal NanoparticlesLimit of Detection

Stichwörter der Autor:innen

colorimetriclateral flow immunoassaypaper‐based microfluidicswhole blood detection

Substanzen

Cell-Free Nucleic AcidsGoldDNA, Viral

Autor:innen und Institutionen

  • Department of Chemistry, Fudan University, Shanghai, 200438, China.
  • Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.

ORCID-Profile: Hui Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Municipality
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission

Zitieren

APA

Cun, F., Li, H., Wang, H., Yang, B., Kong, J., & Chen, H. (2025). A Fully Integrated ICP‐Enriched and Nanozyme‐Catalyzed Lateral Flow Assay for cfDNA Detection in Whole Blood. Small, 21(8). https://doi.org/10.1002/smll.202408101

Vancouver

Cun F, Li H, Wang H, Yang B, Kong J, Chen H. A Fully Integrated ICP‐Enriched and Nanozyme‐Catalyzed Lateral Flow Assay for cfDNA Detection in Whole Blood. Small. 2025;21(8). doi:10.1002/smll.202408101

BibTeX
@article{Cun2025,
  author = {Cun, Fei and Li, Hanxue and Wang, Haonan and Yang, Bin and Kong, Jilie and Chen, Hui},
  title = {A Fully Integrated ICP‐Enriched and Nanozyme‐Catalyzed Lateral Flow Assay for cfDNA Detection in Whole Blood},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {8},
  doi = {10.1002/smll.202408101}
}
Kostenlos starten →